X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (51) 51
index medicus (50) 50
male (40) 40
female (35) 35
middle aged (34) 34
adult (31) 31
pharmacology & pharmacy (27) 27
antiviral agents - therapeutic use (26) 26
genotype (22) 22
hepatitis c virus (21) 21
hepatitis c, chronic - drug therapy (21) 21
treatment outcome (21) 21
analysis (19) 19
ribavirin (19) 19
virology (19) 19
infectious diseases (18) 18
retrospective studies (16) 16
care and treatment (14) 14
interferon (14) 14
hcv (13) 13
hepatitis c (13) 13
therapy (13) 13
genetic aspects (12) 12
pharmacogenetics (12) 12
ribavirin - therapeutic use (12) 12
biological response modifiers (11) 11
health aspects (11) 11
hepatitis b (11) 11
interferon-alpha - therapeutic use (11) 11
drug therapy, combination (10) 10
hepacivirus - drug effects (10) 10
hepacivirus - genetics (10) 10
hepatitis c - drug therapy (10) 10
hepatitis c, chronic - genetics (10) 10
hepatitis c, chronic - virology (10) 10
infection (10) 10
prospective studies (10) 10
antiviral agents - administration & dosage (9) 9
antiviral agents - blood (9) 9
entecavir (9) 9
hepatitis b, chronic - drug therapy (9) 9
interleukins - genetics (9) 9
polymorphism, single nucleotide - genetics (9) 9
aged (8) 8
antiviral agents (8) 8
antiviral agents - pharmacokinetics (8) 8
hbv (8) 8
hepatitis (8) 8
methods (8) 8
polymorphism, single nucleotide (8) 8
telaprevir (8) 8
chronic hepatitis-c (7) 7
guanine - analogs & derivatives (7) 7
hepatitis c, chronic - complications (7) 7
microbiology (7) 7
antiviral agents - adverse effects (6) 6
hepatitis b e antigens - blood (6) 6
hepatitis b virus - genetics (6) 6
il28b (6) 6
lamivudine (6) 6
patients (6) 6
polyethylene glycols - therapeutic use (6) 6
receptors, calcitriol - genetics (6) 6
recombinant proteins - therapeutic use (6) 6
ribavirin - administration & dosage (6) 6
viral load (6) 6
chemistry, analytical (5) 5
chromatography, high pressure liquid - methods (5) 5
cohort studies (5) 5
dna, viral - blood (5) 5
drug therapy (5) 5
gastroenterology & hepatology (5) 5
genotype 1 (5) 5
genotypes (5) 5
hepatitis b, chronic - virology (5) 5
hepatitis c - genetics (5) 5
infectious disease (5) 5
oligopeptides - blood (5) 5
pegylated interferon (5) 5
pharmacokinetics (5) 5
plasma (5) 5
polymorphisms (5) 5
reproducibility of results (5) 5
ribavirin - adverse effects (5) 5
ribavirin - pharmacokinetics (5) 5
tandem mass spectrometry (5) 5
tandem mass spectrometry - methods (5) 5
vasculitis (5) 5
virological response (5) 5
virus (5) 5
anemia (4) 4
c virus-infection (4) 4
calibration (4) 4
chromatography (4) 4
cirrhosis (4) 4
genes (4) 4
guanine - therapeutic use (4) 4
hepacivirus - isolation & purification (4) 4
hepacivirus - physiology (4) 4
hepatitis c, chronic - blood (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Medical Virology, ISSN 0146-6615, 11/2016, Volume 88, Issue 11, pp. 1953 - 1959
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 06/2018, Volume 90, Issue 6, pp. 1047 - 1052
An alternative approach in the treatment of chronic hepatitis B (CHB) with pegylated (PEG)‐interferon (IFN) is the prolonged course to 96 weeks of therapy,... 
HBV | extended therapy | genotype E | HBeAg‐negative | PEG‐IFN | PEG-IFN | HBeAg-negative | ENTECAVIR | THERAPY | VIROLOGY | HBSAG DECLINE | PREDICTION | Care and treatment | Interferon | Genetic aspects | Analysis | Viral antigens | Hepatitis B | Hepatitis B e antigen | Hepatitis | Genotype & phenotype | Therapy | Hepatitis B surface antigen | Hepatitis B virus | Multivariate analysis | Patients | Genotypes
Journal Article
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, ISSN 1341-321X, 07/2019
The presence of psychiatric disorders (PD) in patients affected by chronic hepatitis C (CHC) was a major contraindication for the treatment with interferon... 
Journal Article
Infection, ISSN 0300-8126, 10/2018, Volume 46, Issue 5, pp. 607 - 615
Journal Article
Antiviral Therapy, ISSN 1359-6535, 2018, Volume 23, Issue 6, pp. 543 - 547
Background: The novel available interferon (IFN)-free regimens significantly improved the sustained virological response (SVR) in patients with chronic... 
INFECTIOUS DISEASES | VELPATASVIR | VIROLOGY | HEPATITIS-C VIRUS | SEQUENCES | NS5A | RESISTANCE | PHARMACOLOGY & PHARMACY | INFECTION | ANTIVIRAL DRUGS
Journal Article
Archives of Virology, ISSN 0304-8608, 4/2018, Volume 163, Issue 4, pp. 961 - 967
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 11/2016, Volume 88, Issue 11, pp. 1953 - 1959
Journal Article
Minerva Medica, ISSN 0026-4806, 04/2018, Volume 109, Issue 2, pp. 69 - 70
Journal Article
Antiviral Therapy, ISSN 1359-6535, 2018, Volume 23, Issue 4, pp. 373 - 377
Background: Recently, due to its high effectiveness and tolerability, the treatment of chronic hepatitis B with entecavir became a standard practice. However,... 
INFECTIOUS DISEASES | THERAPY | PLASMA | VIROLOGY | EFFICACY | HBSAG LOSS | ANALOGS | UPLC-MS/MS METHOD | QUANTIFICATION | DECREASE | PHARMACOLOGY & PHARMACY
Journal Article
Journal Article
Journal Article
Journal Article
by Bertoli, Ada and Sorbo, Maria Chiara and Aragri, Marianna and Lenci, Ilaria and Teti, Elisabetta and Polilli, Ennio and Di Maio, Velia Chiara and Gianserra, Laura and Biliotti, Elisa and Masetti, Chiara and Magni, Carlo F and Babudieri, Sergio and Nicolini, Laura A and Milana, Martina and Cacciatore, Pierluigi and Sarmati, Loredana and Pellicelli, Adriano and Paolucci, Stefania and Craxì, Antonio and Morisco, Filomena and Palitti, Valeria Pace and Siciliano, Massimo and Coppola, Nicola and Iapadre, Nerio and Puoti, Massimo and Rizzardini, Giuliano and Taliani, Gloria and Pasquazzi, Caterina and Andreoni, Massimo and Parruti, Giustino and Angelico, Mario and Perno, Carlo Federico and Cento, Valeria and Ceccherini-Silberstein, Francesca and Andreone, Pietro and Baldanti, Fausto and Barbarini, Giorgio and Boccaccio, Vincenzo and Boglione, Lucio and Bolis, Matteo and Bonora, Stefano and Borghi, Vanni and Brancaccio, Giuseppina and Bruno, Savino and Bruzzone, Bianca and Calvaruso, Vincenza and Caporaso, Nicola and Ciaccio, Antonio and Ciancio, Alessia and Colombatto, Piero and Cozzolongo, Raffaele and D'Ambrosio, Cecilia and D'Ettorre, Gabriella and De Leonardis, Francesco and De Luca, Andrea and Di Biagio, Antonio and Di Perri, Giovanni and Francioso, Simona and Gaeta, Giovanni Battista and Gasbarrini, Antonio and Ghisetti, Valeria and Giorgini, Alessia and Grieco, Antonio and Gubertini, Guido and Gulminetti, Roberto and Lambiase, Lara and Landonio, Simona and Lichtner, Miriam and Maida, Ivana and Marenco, Simona and Marinaro, Letizia and Maserati, Renato and Melis, Michela and Menzaghi, Barbara and Meregalli, Elisa and Micheli, Valeria and Niero, Fosca and Paoloni, Maurizio and Pieri, Alessandro and Rendina, Maria and Romagnoli, Dante and Rossetti, Barbara and Ruggiero, Tina and Sangiovanni, Vincenzo and Starace, Mario and Sticchi, Laura and Tarquini, Pierluigi and Toniutto, Pierluigi and Vullo, Vincenzo and Zazzi, Maurizio and Hcv Virology Italian Resistance Ne and HCV Virology Italian Resistance Network (VIRONET-C)
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 8988 - 11
Natural resistance-associated substitutions (RASs) are reported with highly variable prevalence across different HCV genotypes (GTs). Frequency of natural RASs... 
GLECAPREVIR | TREATMENT-NAIVE | REAL-LIFE | PIBRENTASVIR | CIRRHOSIS | MULTIDISCIPLINARY SCIENCES | SIMEPREVIR PLUS SOFOSBUVIR | RESPONSE RATES | DIRECT-ACTING ANTIVIRALS | 1 INFECTION | OPEN-LABEL | Hepatitis C | Disease resistance | Genotypes
Journal Article